174 related articles for article (PubMed ID: 7748076)
1. Endometrial squamous metaplasia. An unusual response to progestin therapy of hyperplasia.
Miranda MC; Mazur MT
Arch Pathol Lab Med; 1995 May; 119(5):458-60. PubMed ID: 7748076
[TBL] [Abstract][Full Text] [Related]
2. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
Wheeler DT; Bristow RE; Kurman RJ
Am J Surg Pathol; 2007 Jul; 31(7):988-98. PubMed ID: 17592264
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis may be an early event of progestin therapy for endometrial hyperplasia.
Amezcua CA; Lu JJ; Felix JC; Stanczyk FZ; Zheng W
Gynecol Oncol; 2000 Nov; 79(2):169-76. PubMed ID: 11063639
[TBL] [Abstract][Full Text] [Related]
4. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
[TBL] [Abstract][Full Text] [Related]
5. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
Witkiewicz AK; McConnell T; Potoczek M; Emmons RV; Kurman RJ
Hum Pathol; 2010 Jan; 41(1):26-32. PubMed ID: 19733383
[TBL] [Abstract][Full Text] [Related]
6. Clinical and pathological responses of progestin therapy for non-atypical endometrial hyperplasia: a prospective study.
Rattanachaiyanont M; Angsuwathana S; Techatrisak K; Tanmahasamut P; Indhavivadhana S; Leerasiri P
J Obstet Gynaecol Res; 2005 Apr; 31(2):98-106. PubMed ID: 15771634
[TBL] [Abstract][Full Text] [Related]
7. [Endometrial atypical complex hyperplasia with extensive squamous metaplasia: two cases].
Hannachi Sassi S; Dhouib R; Abbes I; Braham E; Mrad K; Driss M; Ben Hamida N; Ben Romdhane K
Ann Pathol; 2008 Jun; 28(3):233-6. PubMed ID: 18706369
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of bcl-2 is a potential marker of the efficacy of progestin therapy in the treatment of endometrial hyperplasia.
Amezcua CA; Zheng W; Muderspach LI; Felix JC
Gynecol Oncol; 1999 Apr; 73(1):126-36. PubMed ID: 10094893
[TBL] [Abstract][Full Text] [Related]
9. Development of metastatic endometrial endometrioid adenocarcinoma while on progestin therapy for endometrial hyperplasia.
Rubatt JM; Slomovitz BM; Burke TW; Broaddus RR
Gynecol Oncol; 2005 Nov; 99(2):472-6. PubMed ID: 16099019
[TBL] [Abstract][Full Text] [Related]
10. Reverse of progestin-resistant atypical endometrial hyperplasia by metformin and oral contraceptives.
Shen ZQ; Zhu HT; Lin JF
Obstet Gynecol; 2008 Aug; 112(2 Pt 2):465-7. PubMed ID: 18669766
[TBL] [Abstract][Full Text] [Related]
11. Endometrial hyperplasia involving endometrial polyps: report of a series and discussion of the significance in an endometrial biopsy specimen.
Kelly P; Dobbs SP; McCluggage WG
BJOG; 2007 Aug; 114(8):944-50. PubMed ID: 17565613
[TBL] [Abstract][Full Text] [Related]
12. Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy.
Penner KR; Dorigo O; Aoyama C; Ostrzega N; Balzer BL; Rao J; Walsh CS; Cass I; Holschneider CH
Gynecol Oncol; 2012 Mar; 124(3):542-8. PubMed ID: 22079678
[TBL] [Abstract][Full Text] [Related]
13. Treatment of endometrial hyperplasia with levonorgestrel releasing intrauterine devices.
Perino A; Quartararo P; Catinella E; Genova G; Cittadini E
Acta Eur Fertil; 1987; 18(2):137-40. PubMed ID: 3115027
[TBL] [Abstract][Full Text] [Related]
14. [Pregnant rate and pregnancy-relating factors of patients with early endometrial carcinoma and severe atypical hyperplasia of endometrium after fertility-preserving treatment by progestin].
Cao DY; Yu M; Yang JX; Shen K; Huang HF; Cheng NH; Sun ZY; Deng CY; Yu Q; He FF
Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):519-22. PubMed ID: 24284224
[TBL] [Abstract][Full Text] [Related]
15. Effects of hormone therapy on the endometrium.
Deligdisch L
Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860
[TBL] [Abstract][Full Text] [Related]
16. [The role of gestagens in prevention and therapy of endometrial hyperplasia].
Römer T
Zentralbl Gynakol; 1995; 117 Suppl():14-8. PubMed ID: 8571687
[No Abstract] [Full Text] [Related]
17. The ability of endometrial biopsies with atypical complex hyperplasia to guide surgical management.
Miller C; Bidus MA; Pulcini JP; Maxwell GL; Cosin JA; Rose GS
Am J Obstet Gynecol; 2008 Jul; 199(1):69.e1-4. PubMed ID: 18241812
[TBL] [Abstract][Full Text] [Related]
18. Clinical use of progestins in the menopausal patient: dosage and duration.
Gambrell RD
J Reprod Med; 1982 Aug; 27(8 Suppl):531-8. PubMed ID: 7131446
[TBL] [Abstract][Full Text] [Related]
19. Endometrial metaplasia associated with endometrial carcinoma.
Kaku T; Tsukamoto N; Tsuruchi N; Sugihara K; Kamura T; Nakano H
Obstet Gynecol; 1992 Nov; 80(5):812-6. PubMed ID: 1407921
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.
Varma R; Soneja H; Bhatia K; Ganesan R; Rollason T; Clark TJ; Gupta JK
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
